TYRA
Tyra Biosciences Inc
20.20$
-3.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.2% | +79.2% | -3.0% | -3.0% | -4.5% | -5.5% | -6.4% | -6.1% | -6.4% | +45.8% | -7.0% | |
| – | -5.8% | +84.6% | -3.1% | -3.4% | -5.0% | -6.6% | -6.9% | -6.9% | -5.6% | +48.7% | -7.0% | |
| – | -73.1% | +338.5% | -60.9% | +4.4% | -11.5% | +9.5% | -2.2% | -37.1% | +24.9% | +9.8% | -13.1% | |
| – | -5.6% | +88.0% | -2.3% | -3.7% | -5.2% | -6.6% | -7.1% | -7.2% | -6.9% | +49.8% | -7.7% | |
| – | – | +114.3% | +26.7% | +0.0% | +5.3% | -10.0% | -5.6% | +29.4% | – | – | – | |
| – | +33.4% | -31.2% | +10.5% | +11.5% | +11.5% | -2.3% | -3.0% | +10.3% | +9.8% | +4.4% | +21.4% | |
| – | +51.1% | -43.2% | +19.1% | +19.2% | +18.0% | -2.4% | -3.3% | +15.3% | +13.9% | +6.4% | +27.9% | |
| – | +89.2% | +32.1% | +3.5% | +3.9% | +3.5% | +3.4% | +3.5% | +3.4% | +3.5% | +3.4% | +3.3% | |
| – | +102.0% | -38.2% | -45.2% | -26.1% | -49.4% | +323.7% | -10.2% | -11.3% | -40.8% | +209.2% | -35.9% | |
| – | -8.1% | +90.9% | -3.5% | -3.7% | -5.3% | -5.7% | -6.6% | -7.2% | -7.6% | +49.5% | -8.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +21.6% | +12.3% | +0.4% | +0.0% | +0.8% | +0.4% | +0.2% | -0.1% | +3.6% | +6.9% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.